kaurenoic acid has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleixo, DT; Corrêa, JODA; Costa, DS; da Silva Filho, AA; Ferreira, KCB; Gameiro, J; Gualberto, ACM; Oliveira, LL; Pittella, F; Santos, MM; Silva, LM; Tavares, GD; Valle, ABCDS | 1 |
| Alves, ÂVF; Amaral, RG; Ambrósio, SR; Cardoso, JC; Chagas-Neto, JL; de Albuquerque-Júnior, RLC; Gondak, RO; Melo, CR; Moreira, MR; Severino, P; Souto, EB; Veneziani, RCS | 1 |
2 other study(ies) available for kaurenoic acid and Benign Neoplasms
| Article | Year |
|---|---|
Kaurenoic acid nanocarriers regulates cytokine production and inhibit breast cancer cell migration.
Topics: Animals; Cell Movement; Cytokines; Female; Gene Expression; Interleukin-6; Matrix Metalloproteinase 9; Neoplasms; Tumor Necrosis Factor-alpha | 2022 |
Ent-kaurenoic acid-enriched Mikania glomerata leaves-complexed β-cyclodextrin: Pharmaceutical development and in vivo antitumor activity in a sarcoma 180 mouse model.
Topics: Animals; beta-Cyclodextrins; Drug Development; Ki-67 Antigen; Mice; Mikania; Neoplasms; NF-kappa B; Sarcoma 180 | 2023 |